Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

LiveScience

Tuna cans sold at Trader Joe’s, Walmart and Costco recalled due to contamination risk

The recall came after a manufacturing defect in the tuna cans’ ‘easy open’ lids was discovered

The Independent UK

McDonald's improving global sales help to offset US weakness in fourth quarter

Improving international sales helped McDonald’s overcome some weakness at home in the fourth quarter

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Is a new painkiller too good to be true?

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids

Salon

Two million cases of donuts recalled over contamination risk

The recalled donuts were sold in the U.S. and Canada

The Independent UK

IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad

Hims stock surged Friday after facing backlash over its provocative Super Bowl ad.

Investors Business Daily

FDA Warns Of Missed Alerts On Phone-Connected Diabetes Devices, Leading To 'Serious Harm'

The FDA issued an alert warning diabetes patients and caregivers about potential issues with smartphone alerts for continuous glucose monitors.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

A gentler drug overdose reversal

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose

Salon

FDA Warns Of Health Risks From Diabetes App Notifications

FDA warns of health risks from missed alerts on diabetes management apps, emphasizing the need for proper device functioning to ensure patient safety.

Top News

Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.

Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares quadruple last year.

Investors Business Daily

Patients using diabetes apps can miss critical alerts. Here's how to make sure you're getting them

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes

The Independent UK

RFK Jr.'s plan for ultra-processed foods

Kennedy is Trump's top pick to lead the U.S. Department of Health and Human Services (HHS)

Salon

First new non-opioid painkiller approved in the US for decades – here’s how it works

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades.

The Conversation

Patients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Earnings Miss? Amgen’s Dividend Still a Bright Spot

AMGN stock is down over 1% despite beating revenue and earnings estimates; investors are selling the news on the company’s latest obesity drug and weak guidance

Investors Business Daily

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.

RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines to send his nomination to the full chamber.

Salon

FDA elevates chocolate recall risk

The products were sold throughout nine states and online

USA Today Sports Media Group

Ensure Device Safety and Compliance with FDA-Approved Cybersecurity Standards”

With the rapid integration of technology into healthcare, the need for robust cybersecurity measures has become a non-negotiable. Medical devices, which increasingly rely on software and connectivity, bring unprecedented convenience and improved ...

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescribed.

The Independent UK

Baby teething sticks recalled over 'potential choking hazard’

The recalled baby teething product was sold in 45 states

Salon

Lay's potato chip recalled over allergen

There is a "warning of potentially serious or even deadly consequences from consuming the product"

Tom’s Hardware

Backdoor uncovered in China-made patient monitors — Contec CMS8000 raises questions about healthcare device security

The CISA and FDA have released security warnings about the Contec CMS8000, which is used for patient monitoring.

LiveScience

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

LiveScience

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

The Independent UK

Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’

Three products from Cal Yee Farm’s recall last month are now a ‘Class 1’ level

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.